fda zepbound news - Search News

FDA, Zepbound and obstructive sleep apnea

INSIDER on MSN · 19h

The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.

People on MSN · 16h

FDA Approves Weight Loss Medication Zepbound to Treat Sleep Apnea

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as tirzepatide, to help people treat their obstructive sleep apnea.

FDA approves Zepbound for obstructive sleep apnea

Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep apnea.

1don MSN

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

Everyday Health1d

FDA Says Shortages of GLP-1 Drugs Mounjaro and Zepbound Are Over

Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results